DTIL•benzinga•
Precision BioSciences Reveals Presentation Of Initial Safety Data From Phase 1 ELIMINATE-B Trial Evaluating PBGENE-HBV At 2025 European Association For Study Of Liver Congress (EASL)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 7, 2025 by benzinga